BUSINESS

Emcure Repositions Poviztra with Sharp Price Cut to Drive Market Penetration

Emcure Pharmaceuticals Ltd. has announced a strategic price revision for its obesity drug Poviztra® (semaglutide injection), reducing prices by up to 55% in a bid to expand market penetration in India. The revised monthly price…

Apr 16, 2026